Cancer
Showing of 68 results
Team of Researchers, including University Hospitals Co–Senior Author, Finds not all Low-Grade Prostate Cancers are Low Risk
The study, published July 31 in the journal JAMA Oncology, found that one in six men with GG1 category cancer turns out to have intermediate- or high-risk cancer when other clinical features are considered in addition to biopsy results.
St. Baldrick’s Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study
The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.
Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy
University Hospitals Seidman Cancer Center researcher on team who made the first of its kind discovery published in Oncotarget.
Northeast Ohio Children’s Hospitals and Dunkin’ Joy in Childhood Foundation Host Prom for Teen Cancer Patients and Survivors
On Friday, June 13, more than 48 local teens battling cancer or in recovery, along with their special guests, will celebrate an unforgettable night at the “Let’s Glow” prom event.
University Hospitals Seidman Cancer Center Receives Funding to Implement Improved Symptom Monitoring for Patients Undergoing Cancer Treatment
University Hospitals Seidman Cancer Center Receives Funding to Implement Improved Symptom Monitoring for Patients Undergoing Cancer Treatment.
University Hospitals Seidman Cancer Center to Host Northeast Ohio’s Premier Culinary Event ─ Five Star Sensation ─ June 28
Vinnie Cimino, Chef/Partner of Cordelia, returns to lead this year’s lineup of internationally renowned chefs and vintners.
UH Cleveland Medical Center Activates AI for Early Lung Cancer Identification
‘Second set of eyes’ aims to help physicians find small pulmonary nodules
International Harrington Prize Awarded to Dr. Owen Witte
2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies.